Corbus Pharmaceuticals Reports Second Quarter Financial Results and Corporate Updates
RESOLVE-1 Phase 3 study of lenabasum for treatment of systemic sclerosis on schedule for topline data this summerPhase 2b study […]
RESOLVE-1 Phase 3 study of lenabasum for treatment of systemic sclerosis on schedule for topline data this summerPhase 2b study […]
SALT LAKE CITY, Aug. 06, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and […]
All amounts in U.S. dollars unless otherwise statedTORONTO, Aug. 06, 2020 (GLOBE NEWSWIRE) — Onex Corporation (TSX: ONEX) today announced […]
TORONTO, Aug. 06, 2020 (GLOBE NEWSWIRE) — O3 Mining Inc. (TSX.V:OIII) (“O3 Mining” or the “Corporation”) is pleased to announce […]
Further Strengthened Liquidity Position with Highly Successful $1.5 Billion Triple-Tranche Capital RaiseCompany Well-Positioned to Withstand Prolonged Voyage SuspensionsFormed Healthy Sail [...]
Key Highlights:Net sales revenue increased approximately 11% to $6.4 millionGross profit continues to show improvement year-over-year as a result of […]
CHICAGO and LAS VEGAS, Aug. 06, 2020 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), […]
MALVERN, Pa., Aug. 06, 2020 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute […]
Houston, Texas, Aug. 06, 2020 (GLOBE NEWSWIRE) — Extension of collaboration between UTHealth and Immatics until end of 2024 providing […]
DEVON, Pa., Aug. 06, 2020 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies […]